Plotkin SR - Search Results

1

Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.

Plotkin SR, O'Donnell CC, Curry WT, Bove CM, MacCollin M, Nunes FP. Plotkin SR, et al. J Neurosurg Spine. 2011 Apr;14(4):543-7. doi: 10.3171/2010.11.SPINE10350. Epub 2011 Feb 4. J Neurosurg Spine. 2011. PMID: 21294614

2

Value of PET in the assessment of patients with neurofibromatosis type 1.

Bredella MA, Torriani M, Hornicek F, Ouellette HA, Plamer WE, Williams Z, Fischman AJ, Plotkin SR. Bredella MA, et al. Among authors: plotkin sr. AJR Am J Roentgenol. 2007 Oct;189(4):928-35. doi: 10.2214/AJR.07.2060. AJR Am J Roentgenol. 2007. PMID: 17885067

3

Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.

James MF, Lelke JM, Maccollin M, Plotkin SR, Stemmer-Rachamimov AO, Ramesh V, Gusella JF. James MF, et al. Among authors: plotkin sr. Neurobiol Dis. 2008 Feb;29(2):278-92. doi: 10.1016/j.nbd.2007.09.002. Epub 2007 Sep 19. Neurobiol Dis. 2008. PMID: 17962031 Free PMC article.

4

Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.

Plotkin SR, Singh MA, O'Donnell CC, Harris GJ, McClatchey AI, Halpin C. Plotkin SR, et al. Nat Clin Pract Oncol. 2008 Aug;5(8):487-91. doi: 10.1038/ncponc1157. Epub 2008 Jun 17. Nat Clin Pract Oncol. 2008. PMID: 18560388

5

Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II.

Harris GJ, Plotkin SR, Maccollin M, Bhat S, Urban T, Lev MH, Slattery WH. Harris GJ, et al. Among authors: plotkin sr. Neurosurgery. 2008 Jun;62(6):1314-9; discussion 1319-20. doi: 10.1227/01.neu.0000333303.79931.83. Neurosurgery. 2008. PMID: 18824998

6

Patient and physician attitudes regarding clinical trials in neurofibromatosis 1.

McQueen M, MacCollin M, Gusella J, Plotkin SR. McQueen M, et al. Among authors: plotkin sr. J Neurosci Nurs. 2008 Dec;40(6):341-5. doi: 10.1097/01376517-200812000-00005. J Neurosci Nurs. 2008. PMID: 19170300

7

Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.

Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E. Plotkin SR, et al. N Engl J Med. 2009 Jul 23;361(4):358-67. doi: 10.1056/NEJMoa0902579. Epub 2009 Jul 8. N Engl J Med. 2009. PMID: 19587327 Free PMC article.

8

Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas.

Shen Y, Nunes F, Stemmer-Rachamimov A, James M, Mohapatra G, Plotkin S, Betensky RA, Engler DA, Roy J, Ramesh V, Gusella JF. Shen Y, et al. BMC Med Genomics. 2009 Jul 9;2:42. doi: 10.1186/1755-8794-2-42. BMC Med Genomics. 2009. PMID: 19589153 Free PMC article.

9

Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.

Plotkin SR, Halpin C, McKenna MJ, Loeffler JS, Batchelor TT, Barker FG 2nd. Plotkin SR, et al. Otol Neurotol. 2010 Sep;31(7):1135-43. doi: 10.1097/MAO.0b013e3181eb328a. Otol Neurotol. 2010. PMID: 20736812 Free PMC article.

10

Exacerbation of cerebral radiation necrosis by bevacizumab.

Jeyaretna DS, Curry WT Jr, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR. Jeyaretna DS, et al. Among authors: plotkin sr. J Clin Oncol. 2011 Mar 1;29(7):e159-62. doi: 10.1200/JCO.2010.31.4815. Epub 2010 Dec 13. J Clin Oncol. 2011. PMID: 21149667 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters